Accelerant initiated with an Outperform at Raymond James

Raymond James initiated coverage of Accelerant (ARX) with an Outperform rating and $33 price target Accelerant is a unique growth story in the specialty P&C insurance market and the company should be positioned to grow revenue and free cash flow at a double-digit annual rate with 300 basis points or more of margin expansion year over year through 2027, the analyst tells investors in a research note. Accelerant’s gradual strategic shift toward a predominantly fee-based model should enhance and stabilize its margin profile, the firm says.